Department of Health and Social Care
Faster access to cannabis-based medicines as import restrictions are changed
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
Import restrictions have been changed to help ensure people with prescriptions for cannabis-based products for medicinal use do not have their treatment delayed or interrupted.
The changes will help patients with conditions such as rare, serious forms of epilepsy or multiple sclerosis.
Licensed wholesalers will now be able to:
- import larger quantities of cannabis-based products
- hold supplies for future use by patients with prescriptions
Most cannabis-based medicines are imported from foreign countries. Export restrictions mean it can take weeks or months for the drugs to reach the patients in the UK. For example, in Canada, an export certificate can take 4 to 8 weeks.
In addition, safeguards against addiction and the misuse of drugs mean that patients with prescriptions for unlicensed medicines, such as medicinal cannabis, need to have their prescription reviewed every 30 days by specialist doctors. This can lead to delays in treatment if there are also delays to imports.
The new measures will be implemented by the Home Office and the Medicines and Healthcare products Regulatory Agency (MHRA) from 2 March.
It follows the law change in October 2018 to allow specialist doctors to prescribe cannabis-based products for medicinal use where clinically appropriate in the UK.
The government is working with industry to explore further ways to reduce costs and encourage more research into uninterrupted access to cannabis-based medicinal products where clinically appropriate.
The government will also continue to engage with medical associations and patients to build evidence, using trials in the UK to accelerate our understanding of how medicinal cannabis can benefit patients. This is necessary for wider prescribing by NHS clinicians in future.
In November last year, the National Institute for Health and Care Excellence (NICE) recommended 2 cannabis-based medicinal products for patients with multiple sclerosis and hard-to-treat epilepsies.
The Department of Health and Social Care continues to work closely with NHS England-NHS Improvement (NHSE-I) and the National Institute of Health Research (NIHR) to establish clinical trials to develop the evidence-base to support further commissioning decisions.
Health and Social Care Secretary Matt Hancock yesterday said:
Every time I meet the families of young people dealing so bravely with childhood epilepsy, I am reminded of just how much they have been through.
The changes made today are a tremendous step towards improving the supply of cannabis-based medicinal products by helping to ensure quicker and more reliable access for patients.
But we still have a long way to go. We need more research into the quality and safety of these medicines, and to do all we can to cut down the costs and remove barriers so that, when appropriate, patients can access it, including on the NHS.
Home Secretary Priti Patel yesterday said:
I have taken swift action to allow specialist doctors to issue prescriptions for cannabis-based medicinal products, when they consider their patients would benefit from this treatment.
This will allow patients and their families with challenging conditions to access them more easily, when appropriate, to ensure they can be treated in days, not months.
Latest News from
Department of Health and Social Care
Government asks regulator to approve supply of Oxford/AstraZeneca vaccine27/11/2020 11:30:00
The government has formally asked the Medicines and Healthcare products Regulatory Agency to evaluate whether supply of Oxford/AstraZeneca vaccine can be authorised.
Record numbers of doctors and 14,813 more nurses working in the NHS27/11/2020 11:10:00
NHS workforce data for August shows the number of nurses in the NHS in England increased by 14,813 compared to last year, and the number of doctors rose to a record 121,726.
New UK Government Covid testing site opens in Easterhouse, Glasgow27/11/2020 10:10:10
The UK Government has opened a new walk-through coronavirus testing centre at Glasgow Club Easterhouse.
Renewing regional coronavirus restrictions in England26/11/2020 15:10:00
The Health and Social Care Secretary spoke to the House of Commons about the coronavirus situation and returning to strenghtened local COVID restriction tiers.
Tiering decisions to be made through national command structure26/11/2020 13:10:00
All local authorities in England to be placed in one of 3 tiers based on the latest available data.
Health and Social Care Secretary announces bureaucracy-busting drive25/11/2020 13:10:10
The new drive seeks to empower frontline health and care staff by reducing unnecessary bureaucracy and locking in positive change seen during the pandemic.
Busting bureaucracy for people working on the frontline24/11/2020 16:10:00
Health and Social Care Secretary Matt Hancock spoke at the NHS Confederation’s NHS Reset Conference about a new strategy to reduce bureaucracy.
Test to Release: England introduces testing strategy for international arrivals24/11/2020 13:12:00
Tests will be at the cost of the traveller to protect the capacity of NHS Test and Trace.
Government welcomes the MHRA review into Pfizer and BioNTech vaccine24/11/2020 10:10:10
UK’s independent regulator to evaluate latest data from Pfizer and BioNTech to ensure the quality, safety and effectiveness of the vaccine meets the standards required.